Low levels of RARβ are potentially one of the mechanisms leading to reduced uptake of iodine by tumor cells and ineffectiveness of radioiodine therapy, significantly worsening the prognosis of thyroid cancer patients. The gene discussed is RARB; the disease is thyroid gland carcinoma.